User profiles for Sophie M Rose

Sophie M Rose

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
Verified email at jh.edu
Cited by 92

Analysing COVID-19 outcomes in the context of the 2019 Global Health Security (GHS) Index

SM Rose, M Paterra, C Isaac, J Bell, A Stucke… - BMJ global …, 2021 - gh.bmj.com
Introduction The Global Health Security Index benchmarks countries’ capacities to carry out
the functions necessary to prevent, detect and respond to biological threats. The COVID-19 …

Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development

…, CW Bakerlee, TG McKelvey, SM Rose… - Clinical Infectious …, 2021 - academic.oup.com
Human challenge trials (HCTs) have been proposed as a means to accelerate SARS-CoV-2
vaccine development. We identify and discuss 3 potential use cases of HCTs in the current …

Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder

MG Mariscal, O Oztan, SM Rose, RA Libove… - Autism …, 2019 - Wiley Online Library
Research suggests that children with autism spectrum disorder (ASD) may have reduced
empathy, as measured by an impaired contagious yawn response, compared to typically …

Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials

SM Rose, VL Schmit, TC Darton, N Eyal, M Magalhaes… - medRxiv, 2021 - medrxiv.org
In human challenge trials, volunteers are deliberately infected with a pathogen to accelerate
vaccine development and answer key scientific questions. In the US, preparations for …

[HTML][HTML] Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials

AA Marsh, M Magalhaes, M Peeler, SM Rose… - PloS one, 2022 - journals.plos.org
In human challenge trials (HCTs), volunteers are deliberately infected with an infectious
agent. Such trials can be used to accelerate vaccine development and answer important …

National Surveillance for Novel Diseases: A Systematic Analysis of 195 Countries

C Nelson, SM Rose, V Sachdev, RN Thompson… - papers.ssrn.com
Background: Pandemics caused by novel pathogens produce devastating global effects.
Early detection is critical, and the International Health Regulations (2005)(IHR [2005]) require …

Evaluating use cases for human challenge trials in accelerating COVID-19 vaccine development

LC Nguyen, CW Bakerlee, TG McKelvey, SM Rose… - osf.io
Recently, human challenge trials (HCTs) have been proposed as a means to accelerate the
development of an effective SARS-CoV-2 vaccine. In this paper, we discuss the potential …

Attitudes of Human Challenge Volunteers: A Study of Controlled Human COVID-19 Infection Trial Volunteers' Pro-Sociality, Risk-Taking Behavior and Motivations

SM Rose - 2020 - osf.io
The purpose of this study is to characterize a volunteer population willing to consent to
SARS-CoV-2 vaccine human challenge trials (HCTs). These features include volunteers’ pro-…

Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials (preprint)

SM Rose, VL Schmit, TC Darton, N Eyal, M Magalhaes… - 2021 - pesquisa.bvsalud.org
In human challenge trials, volunteers are deliberately infected with a pathogen to accelerate
vaccine development and answer key scientific questions. In the US, preparations for …

A qnr-plasmid allows aminoglycosides to induce SOS in Escherichia coli

…, G Sophie, B Fethi, V Sébastien, M Sophie, M Didier… - eLife, 2022 - search.proquest.com
The plasmid-mediated quinolone resistance (PMQR) genes have been shown to promote
high-level bacterial resistance to fluoroquinolone antibiotics, potentially leading to clinical …